MESDC2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.696600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.720400E-01
Normal-vs-Stage2
5.560600E-01
Normal-vs-Stage3
4.126600E-01
Normal-vs-Stage4
5.755800E-01
Stage1-vs-Stage2
9.669200E-01
Stage1-vs-Stage3
8.102100E-02
Stage1-vs-Stage4
8.650600E-01
Stage2-vs-Stage3
1.131760E-01
Stage2-vs-Stage4
8.899400E-01
Stage3-vs-Stage4
2.413600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.659200E-01
Normal-vs-AfricanAmerican
3.569600E-01
Normal-vs-Asian
7.569400E-01
Caucasian-vs-AfricanAmerican
7.508400E-01
Caucasian-vs-Asian
8.356400E-01
AfricanAmerican-vs-Asian
7.528200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.756200E-01
Normal-vs-Female
5.680000E-01
Male-vs-Female
7.267400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.857800E-01
Normal-vs-Age(41-60Yrs)
3.212800E-01
Normal-vs-Age(61-80Yrs)
7.427600E-01
Normal-vs-Age(81-100Yrs)
4.911600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.701400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.299600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.097200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.244500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.607000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.231800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.831800E-01
Normal-vs-Daily Drinker
9.506800E-01
Normal-vs-Weekly Drinker
8.195000E-01
Normal-vs-Occasional Drinker
4.227400E-01
Normal-vs-Social Drinker
7.821600E-01
Non Drinker-vs-Daily Drinker
4.001800E-01
Non Drinker-vs-Weekly Drinker
7.257000E-01
Non Drinker-vs-Occasional Drinker
3.532400E-01
Non Drinker-vs-Social Drinker
6.385400E-01
Daily Drinker-vs-Weekly Drinker
7.155800E-01
Daily Drinker-vs-Occasional Drinker
8.974200E-02
Daily Drinker-vs-Social Drinker
7.311200E-01
Weekly Drinker-vs-Occasional Drinker
2.783800E-01
Weekly Drinker-vs-Social Drinker
9.410400E-01
Occasional Drinker-vs-Social Drinker
1.736610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.142800E-01
Normal-vs-Grade 2
8.349200E-01
Normal-vs-Grade 3
7.882600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.877360E-01
Grade 1-vs-Grade 3
3.712300E-02
Grade 1-vs-Grade 4
9.142800E-01
Grade 2-vs-Grade 3
3.401400E-01
Grade 2-vs-Grade 4
8.349200E-01
Grade 3-vs-Grade 4
7.882600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.716000E-01
Normal-vs-NonDiabetic
5.421000E-01
Diabetic-vs-NonDiabetic
1.321150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.540800E-01
Normal-vs-NoPancreatitis
6.125600E-01
Pancreatitis-vs-NoPancreatitis
6.560000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.665200E-01
Normal-vs-N1
5.502400E-01
N0-vs-N1
3.196800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.958400E-01
Normal-vs-TP53-NonMutant
6.883600E-01
TP53-Mutant-vs-TP53-NonMutant
5.322500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
